RedHill Biopharma (RDHL) EBT Margin Growth (5y) (2017 - 2023)
RedHill Biopharma (RDHL) EBT Margin Growth (5y) (2017 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | RedHill Biopharma | 640,064.98 | 640,064.98 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 294,042.00 |
| Mar 31, 2023 | -63,128.00 |
| Dec 31, 2022 | -145,871.00 |
| Sep 30, 2022 | -93,777.00 |
| Jun 30, 2022 | -328,800.00 |
| Mar 31, 2022 | 23.23 Mn |
| Jun 30, 2021 | -78.35 Mn |
| Dec 31, 2020 | -985,551.00 |
| Jun 30, 2020 | -51.84 Mn |
| Mar 31, 2020 | -48.52 Mn |
| Dec 31, 2019 | -39.75 Mn |
| Sep 30, 2019 | 72,933.00 |
| Jun 30, 2019 | -9.17 Mn |
| Mar 31, 2019 | 44,436.00 |
| Dec 31, 2018 | -35.11 Mn |
| Sep 30, 2018 | 9.02 Mn |
| Jun 30, 2018 | 6.30 Mn |
| Mar 31, 2018 | 4.97 Mn |
| Dec 31, 2017 | 2.03 Mn |
| Sep 30, 2017 | 5.98 Mn |